- Home
- OPK vs BUR Comparison
OPK vs BUR Comparison
Compare OPK & BUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPK | BUR |
|---|---|---|
| Founded | 2006 | 2009 |
| Country | United States | Guernsey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2011 | 2017 |
Fundamental Metrics
Financial Performance| Metric | OPK | BUR |
|---|---|---|
| Price | $1.50 | $4.43 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $1.60 | ★ $13.58 |
| AVG Volume (30 Days) | ★ 4.3M | 1.6M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $606,879,000.00 | $413,360,000.00 |
| Revenue This Year | N/A | $104.62 |
| Revenue Next Year | $4.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.98 | $3.59 |
| 52 Week High | $1.73 | $14.05 |
Technical Indicators
Market Signals| Indicator | OPK | BUR |
|---|---|---|
| Relative Strength Index (RSI) | 62.48 | 56.07 |
| Support Level | $1.26 | $4.42 |
| Resistance Level | $1.55 | $4.53 |
| Average True Range (ATR) | 0.05 | 0.16 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 87.50 | 78.67 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About BUR Burford Capital Limited
Burford Capital Ltd provides capital against the underlying value of litigation and legal assets, known as legal finance, serving the legal industry with financial products and services. Its business is funding clients engaged in ongoing legal disputes to pay legal fees and monetize the expected future value of disputes, focusing on large, complex matters. The company has two reportable segments: Principal Finance, which earns maximum revenue and allocates capital to legal finance assets from its balance sheet and through interests in private funds managed by the company, and Asset Management and Other Services, which manages legal finance assets for third-party investors and provides other services to the legal industry.